精神刺激薬精神病
□記事を途中から表示しています
[最初から表示]
^ Connell, P.H. Amphetamin Psychosis, Maudsley Monograph NO.5. Chapman & Hall, London, 1958
^ a b 山下格、森田昭之助『覚醒剤中毒』金剛出版、1980年、41,56,91頁。
^ Smart RG (1976). ⇒“Effects of legal restraint on the use of drugs: a review of empirical studies”. U.N. Bulletin on Narcotics 28 (1): 55?65. PMID 1046373. ⇒http://www.unodc.org/unodc/en/data-and-analysis/bulletin/bulletin_1976-01-01_1_page006.html.
^ a b “Amphetamine (Version: 4.05)”. Drugs.com (2009年4月12日). 2014年6月8日閲覧。
^ a b c Shoptaw, Steven J; Kao, Uyen; Ling, Walter; Shoptaw, Steven J (2009). Treatment for amphetamine psychosis. doi:10.1002/14651858.CD003026.pub3.
^ McKetin R, McLaren J, Lubman DI, Hides L. The prevalence of psychotic symptoms among methamphetamine users. Addiction 2006;101(10):1473?8.
^ Dore, Glenys; Sweeting, Melinda (2006). “Drug-induced psychosis associated with crystalline methamphetamine”. Australasian Psychiatry 14 (1): 86?89. doi:10.1080/j.1440-1665.2006.02252.x.
^ Srisurapanont, Manit; Ali, Robert; Marsden, John; Sunga, Agueda; Wada, Kiyoshi; Monteiro, Maristela (2003). “Psychotic symptoms in methamphetamine psychotic in-patients”. The International Journal of Neuropsychopharmacology 6 (4): 347?352. doi:10.1017/S1461145703003675.
^ a b Sato, M.; Numachi, Y.; Hamamura, T. (1992). ⇒“Relapse of Paranoid Psychotic State in Methamphetamine Model of Schizophrenia”. Schizophrenia Bulletin 18 (1): 115?122. doi:10.1093/schbul/18.1.115. ⇒http://schizophreniabulletin.oxfordjournals.org/content/18/1/115.full.pdf+html.
^ Hofmann FG (1983). A Handbook on Drug and Alcohol Abuse: The Biomedical Aspects (2nd ed.). New York: Oxford University Press. pp. 329
^ Yui, Kunio; Ikemoto, Shigenori; Goto, Kimihiko (2002). “Factors for Susceptibility to Episode Recurrence in Spontaneous Recurrence of Methamphetamine Psychosis”. Annals of the New York Academy of Sciences 965 (1): 292?304. doi:10.1111/j.1749-6632.2002.tb04171.x.
^ Alan F. Schatzberg, Charles B. Nemeroff (2009). The American Psychiatric Publishing Textbook of Psychopharmacology. The American Psychiatric Publishing. pp. 847?48. ISBN 978-1-58562-309-9. https://books.google.co.jp/books?id=Xx7iNGdV25IC&pg=PP1&redir_esc=y&hl=ja
^ Chen, Chih-Ken; Lin, Shih-Ku; Sham, Pak C.; Ball, David; Loh, El-Wui; Murray, Robin M. (2005). “Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis”. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 136B (1): 87?91. doi:10.1002/ajmg.b.30187.
^ McIver C, McGregor C, Baigent M, Spain D, Newcombe D, on behalf of the Guidelines Development Working Party (pdf). ⇒Guidelines for the medical management of patients with methamphetamine-induced psychosis. Drug and Alcohol Services: South Australia, Government of South Australia. ISBN 0-9803130-1-5. ⇒http://www.sahealth.sa.gov.au/wps/wcm/connect/cbad29804178755b94d1ff67a94f09f9/Guidelines+methamphetamine-induced+psychosis-DASSA-Oct2013.pdf?MOD=AJPERES&CACHEID=cbad29804178755b94d1ff67a94f09f9 2014年6月4日閲覧。
^ Sarampote, Christopher S.; Efron, Lisa A.; Robb, Adelaide S.; Pearl, Phillip L.; Stein, Mark A. (2002). ⇒“Can Stimulant Rebound Mimic Pediatric Bipolar Disorder?”. Journal of Child and Adolescent Psychopharmacology 12 (1): 63?67. doi:10.1089/10445460252943588. ⇒http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3554477/.
^ アメリカ精神医学会『DSM-IV-TR 精神疾患の診断・統計マニュアル（新訂版）』医学書院、2004年、249-250頁。ISBN 978-0890420256。
^ Hegerl, U.; Sander, C.; Olbrich, S.; Schoenknecht, P. (2009). “Are Psychostimulants a Treatment Option in Mania?”. Pharmacopsychiatry 42 (05): 169?174. doi:10.1055/s-0029-1220888.
^ Brady KT, Lydiard RB, Malcolm R, Ballenger JC (December 1991). “Cocaine-induced psychosis”. The Journal of Clinical Psychiatry 52 (12): 509?12. PMID 1752853.
^ a b c Thirthalli J., Vivek B. (2006). ⇒“Psychosis Among Substance Users”. Curr Opin Psychiatry 19 (3): 239?245. doi:10.1097/01.yco.0000218593.08313.fd. ⇒http://www.medscape.com/viewarticle/528487_5.
^ Elliott, Amber; Mahmood, Tashfeen; Smalligan, Roger D. (2012). “Cocaine Bugs: A Case Report of Cocaine-Induced Delusions of Parasitosis”. The American Journal on Addictions 21 (2): 180?181. doi:10.1111/j.1521-0391.2011.00208.x.
^ DiSclafani A, Hall RC, Gardner ER (October 1981). “Drug-induced psychosis: emergency diagnosis and management”. Psychosomatics 22 (10): 845?50, 855. doi:10.1016/S0033-3182(81)73092-5. PMID 7313045.
^ Auriel, Eitan; Hausdorff, Jeffrey M.; Giladi, Nir (2009). “Methylphenidate for the Treatment of Parkinson Disease and Other Neurological Disorders”. Clinical Neuropharmacology 32 (2): 75?81. doi:10.1097/WNF.0b013e318170576c.
^ Abramowicz MJ, Van Haecke P, Demedts M, Delcroix M (September 2003). ⇒“Primary pulmonary hypertension after amfepramone (diethylpropion) with BMPR2 mutation”. Eur. Respir. J. 22 (3): 560?2. doi:10.1183/09031936.03.00095303. PMID 14516151. ⇒http://erj.ersjournals.com/content/22/3/560.full.
^ Morton WA, Stockton GG (October 2000). ⇒“Methylphenidate Abuse and Psychiatric Side Effects”. Primary Care Companion to the Journal of Clinical Psychiatry 2 (5): 159?164. PMC 181133. PMID 15014637. ⇒http://www.ncbi.nlm.nih.gov/pmc/articles/PMC181133/.
^ Spensley J, Rockwell D (April 1972). “Psychosis during Methylphenidate Abuse”. New England Journal of Medicine 286: 880?1. doi:10.1056/NEJM197204202861607. PMID 5061074.
次ページ記事の検索おまかせリスト▼オプションを表示暇つぶしWikipedia
Size:53 KB
出典: フリー百科事典『ウィキペディア（Wikipedia）』
担当:undef